duloxetine Recalled for Cancer Risk

This is a news story, published by USA Today, that relates primarily to The U.S. Food and Drug Administration news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

USA Today news

For more news from USA Today, you can click here:

more news from USA Today

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

duloxetine drugs

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest duloxetine news, nitrosoduloxetine news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

duloxetine capsules

USA Today

•

What is duloxetine and how does it work? What to know about antidepressant recalled by FDA

Summary

Nutrition label

70% Informative

More than 233,000 bottles of duloxetine capsules were voluntarily recalled on Nov. 19 .

The U.S. Food and Drug Administration assigned the recall as a class II risk.

The risk level is the FDA 's second most severe level as it could cause "temporary or medically reversible adverse health consequences" The medication had the "presence" of an impurity a potentially cancer-causing substance.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful